SABCS 2022 Patient-Reported Outcomes From the TROPiCS-02 Trial: The Effect of Sacituzumab Govitecan vs. Chemotherapy in HR+/HER2- mBC

64 views
December 13, 2022
Comments 0
Login to view comments. Click here to Login